Get startedLog in
    Picture of SK Biopharmaceuticals Co logo

    326030 — SK Biopharmaceuticals Co News Story

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: SK Biopharmaceuticals Co Signs $17 Million Deal With SK Life Science Inc To Sell Cenobamate In U.S.

    Picture of SK Biopharmaceuticals Co logoSK Biopharmaceuticals Co
    26/09/2022 02:34
    Sept 26 (Reuters) - SK Biopharmaceuticals Co Ltd
 326030.KS :
    * SK BIOPHARMACEUTICALS CO: SIGNS $17 MILLION DEAL WITH SK
LIFE
SCIENCE INC TO SELL CENOBAMATE IN U.S.

Further company coverage:  326030.KS 
 (Reporting by Soo-hyang Choi)
 ((soohyang.choi@thomsonreuters.com;))

    Recent news on SK Biopharmaceuticals Co

    See all news